Olaratumab
Generic Name: olaratumab
Manufactured by ELI LILLY AND CO. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: OLARATUMAB (500MG/50ML). Application: BLA761038.
Overview
Manufactured by ELI LILLY AND CO. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: OLARATUMAB (500MG/50ML). Application: BLA761038.
Dosage
Available as injectable for injection use.
Related Medications
Empagliflozin And Linagliptin
empagliflozin and linagliptin
Sodium-Glucose Cotransporter 2 Inhibitor [EPC]
11 DESCRIPTION GLYXAMBI tablets for oral use contain: empagliflozin and linagliptin. Empagliflozin Empagliflozin is an inhibitor of the SGLT2. The chemical name of empagliflozin is D-Glucitol,1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-, (1S). The molecular formula is C 23 H 27 ClO 7 and the molecular weight is 450.91. The structural formula is: Empagliflozin is a white to yellowish, non-hygroscopic powder.
Yttrium Muriaticum
yttrium muriaticum
Insulin-like Growth Factor-1
insulin-like growth factor-1
PURPOSE Neuroendocrine Support
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.